Anzeige
❌
Mehr »
Donnerstag, 19.11.2026 - Börsentäglich über 12.000 News
Rund 40 Mio. USD Staatsaufträge bis Juni 2029 gebucht: Jetzt zählt die Marge!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
4B

WKN: A3CWA4 | ISIN: GB00BMCLYF79 | Ticker: 88Q
Xetra
19.11.26 | 17:35
5,850 Euro
0,00 % 0,000
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
4BASEBIO PLC Chart 1 Jahr
5-Tage-Chart
4BASEBIO PLC 5-Tage-Chart
RealtimeGeldBriefZeit
5,9006,70022:21

Aktuelle News zur 4BASEBIO Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
Di4basebio Plc - Holding(s) in Company4024basebio Plc - Holding(s) in CompanyPR NewswireLONDON, United Kingdom, November 17 TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BMCLYF79...
► Artikel lesen
Fr4basebio Plc - Holding(s) in Company4994basebio Plc - Holding(s) in CompanyPR NewswireLONDON, United Kingdom, November 13 TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BMCLYF79...
► Artikel lesen
12.11.4basebio Plc - Holding(s) in Company4064basebio Plc - Holding(s) in CompanyPR NewswireLONDON, United Kingdom, November 12 TR-1: Standard form for notification of major holdings NOTIFICATION...
► Artikel lesen
09.11.4basebio: Turning clinical credibility into commercial growth21
09.11.4basebio Plc - Notice of Investor Presentation via Investor Meet Company3064basebio Plc - Notice of Investor Presentation via Investor Meet CompanyPR NewswireLONDON, United Kingdom, November 09 9 November 2026 4basebio PLC ("4basebio" or the...
► Artikel lesen
4BASEBIO Aktie jetzt für 0€ handeln
06.11.4basebio Plc - Result of General Meeting5764basebio Plc - Result of General MeetingPR NewswireLONDON, United Kingdom, November 06 THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED IN IT, IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION...
► Artikel lesen
21.10.4basebio Plc - Result of Retail Offer4664basebio Plc - Result of Retail OfferPR NewswireLONDON, United Kingdom, October 21 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, TO US PERSONS...
► Artikel lesen
20.10.4basebio Plc - Posting of Circular and Notice of General Meeting3904basebio Plc - Posting of Circular and Notice of General MeetingPR NewswireLONDON, United Kingdom, October 20 20 October 2026 4basebio PLC ("4basebio" or the "Company") Posting...
► Artikel lesen
15.10.TRADING UPDATES: 4basebio fundraise; Geo Exploration secures grants4
15.10.4basebio Plc - Proposed Retail Offer6624basebio Plc - Proposed Retail OfferPR NewswireLONDON, United Kingdom, October 15 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, TO US PERSONS...
► Artikel lesen
15.10.4basebio Plc - Results of Capital Raise6584basebio Plc - Results of Capital RaisePR NewswireLONDON, United Kingdom, October 15 THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED IN IT, IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION...
► Artikel lesen
15.10.4basebio Plc - Proposed Capital Raise of New Ordinary Shares to raise not less than £15 million3034basebio Plc - Proposed Capital Raise of New Ordinary Shares to raise not less than £15 millionPR NewswireLONDON, United Kingdom, October 15 THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED...
► Artikel lesen
28.09.4basebio meldet starken Anstieg der Auftragseingänge bei sinkendem Umsatz59
28.09.4basebio reports 210% rise in H1 sales orders amid revenue decline17
28.09.4basebio PLC H1 Loss Rises7
28.09.4BASEBIO PLC: 4basebio and TriLink BioTechnologies Partner to Advance Leading Pharmaceutical Company's Phase I Cell Therapy Program9
07.09.4basebio Plc - 4basebio Expands DNA Offering to Meet Growing Demand for Personalised Medicine7784basebio Plc - 4basebio Expands DNA Offering to Meet Growing Demand for Personalised Medicine PR Newswire LONDON, United Kingdom, September 07 4basebio...
► Artikel lesen
27.08.Genezen to Offer Access to 4basebio Synthetic DNA Platform for Viral Vectors24
26.08.4basebio shares jump on new marketing tie-up with US-based Genezen11
26.08.4basebio and Genezen Enter into Strategic Collaboration to Advance Synthetic, Cell-Free DNA Platforms for Next-Generation Viral Vector Manufacturing481Commercial collaboration combines 4basebio's synthetic DNA technology with Genezen's viral vector development and manufacturing expertise to support gene therapy programs from early development through...
► Artikel lesen
1 2 3 Weiter >>
42 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1